Angiopoietin-like proteins in atherosclerosis

Yi-Zhang Liu,Chi Zhang,Jie-Feng Jiang,Zhe-Bin Cheng,Zheng-Yang Zhou,Mu-Yao Tang,Jia-Xiang Sun,Liang Huang
DOI: https://doi.org/10.1016/j.cca.2021.06.024
IF: 6.314
2021-10-01
Clinica Chimica Acta
Abstract:<p>Atherosclerosis, as a chronic inflammatory disease within the arterial wall, is a leading cause of morbidity and mortality worldwide due to its role in myocardial infarction, stroke and peripheral artery disease. Additional evidence is emerging that the angiopoietin-like (ANGPTL) family of proteins participate in the pathology of this disease process via endothelial dysfunction, inflammation, dyslipidemia, calcification, foam cell formation and platelet activation. This review summarizes current knowledge on the ANGPTL family of proteins in atherosclerosis related pathological processes. Moreover, the potential value of ANGPTL family proteins as predictive biomarkers in atherosclerosis is discussed. Given the attractive role of ANGPTL3, ANGPTL4, ANGPTL8 in atherosclerotic dyslipidemia via regulation of lipoprotein lipase (LPL), antisense oligonucleotide or/and monoclonal antibody-based inactivation of these proteins represent potential atherosclerotic therapies.</p>
medical laboratory technology
What problem does this paper attempt to address?